The US path to a much anticipated rate cut was well-drawn, particularly after Tuesday's CPI report coming along the Fed's ...

Nebius stock surges 120%, driven by ARR acceleration & profitability focus. Explore insights on growth, scaling capacity, and ...

SoundHound AI shines with a strong Q2, 99% projected 2025 revenue growth, and rising QSR momentum. Read my analysis of SOUN ...

Claritev shows revenue growth & client wins, but extreme leverage & legal risks raise concerns. Insider buying adds confidence.

XXRP offers 2x daily XRP exposure. Learn why this ETF needs to be handled with extreme caution and doesn't suit long-term ...

Eli Lilly insiders made notable stock purchases in August, but competitive pressures and pricing risks make me question its ...

Navigate S&P 500 volatility with SDS, a 2x leveraged inverse ETF ideal for short-term trades amidst market catalysts. Click ...

OpenAI employees and former staffers apparently plan to sell up to $6B worth of shares to an investor group, which will propel the company's valuation to a staggering $500B, according to Bloomberg.

Berkshire Hathaway’s UnitedHealth Group Incorporated investment highlights confidence in healthcare. Click for why I am ...

The Vanguard FTSE Developed Markets ETF (NYSEARCA: VEA) is one of the most popular ETFs in the world for gaining exposure to ...

A UK regulator recently approved the acquisition of Spirit AeroSystems by Boeing. Read the latest analysis on the stock here.

Discover why Firefly Aerospace's strong potential isn't enough to warrant a buy. Learn about valuation concerns, cash burn, ...